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Background: RGS-PX proteins are regulators of signaling and trafficking within the endosomal system.
Results: A structural basis for membrane interactions of RGS-PX proteins is established.
Conclusion: The four mammalian paralogues display different membrane interaction properties.
Significance: RGS-PX proteins possess a conserved functional architecture in all eukaryotes.
Sorting nexins (SNXs) or phox homology (PX) domain con-
taining proteins are central regulators of cell trafficking and
signaling. A subfamily of PX domain proteins possesses two
unique PX-associated domains, as well as a regulator of G
protein-coupled receptor signaling (RGS) domain that atten-
uates Gs-coupled G protein-coupled receptor signaling.
Here we delineate the structural organization of these
RGS-PX proteins, revealing a protein family with a modular
architecture that is conserved in all eukaryotes. The one
exception to this is mammalian SNX19, which lacks the typ-
ical RGS structure but preserves all other domains. The PX
domain is a sensor of membrane phosphoinositide lipids and
we find that specific sequence alterations in the PX domains
of the mammalian RGS-PX proteins, SNX13, SNX14, SNX19,
and SNX25, confer differential phosphoinositide binding
preferences. Although SNX13 and SNX19 PX domains bind
the early endosomal lipid phosphatidylinositol 3-phosphate,
SNX14 shows no membrane binding at all. Crystal structures
of the SNX19 and SNX14 PX domains reveal key differences,
with alterations in SNX14 leading to closure of the binding
pocket to prevent phosphoinositide association. Our findings
suggest a role for alternative membrane interactions in
spatial control of RGS-PX proteins in cell signaling and
trafficking.
The sorting nexin (SNX)6 or phox homology (PX) domain-
containing proteins are a large and diverse family of molecules
with many different roles in cellular trafficking and signaling
(1–3). The defining feature of thesemolecules is the presence of
a PX domain, which is coupled to a variety of different func-
tional modules. This core PX structure is generally able to bind
membrane phosphatidylinositol (PtdIns) phospholipids or
phosphoinositides, and thus acts to recruit different functional
activities includingmembrane remodeling, protein scaffolding,
lipid breakdown and synthesis, and GTPase activating (GAP)
domains to membrane-bound compartments of the endocytic
system.
The PX domain is one of a number of cytoplasmic lipid-
bindingmodules that have been shown to bind to specific phos-
phoinositide lipids for membrane recruitment (1, 2, 4–6).
Phosphoinositides are generated by phosphorylation and dephos-
phorylation of PtdIns by phosphoinositide kinases and phospha-
tases at the 3-, 4-, and 5-hydroxyls of the inositol headgroup, and
serve as spatially restricted markers of intracellular organelles by
acting as stereospecific platforms for protein recruitment. For
example, the plasmamembrane is enriched in phosphatidylinosi-
tol 4,5-bisphosphate (PtdIns(4,5)P2), whereas early or sorting
endosomes are enriched with PtdIns3P. The PX domain most
commonly binds to the endosomal lipid marker PtdIns3P,
although other specificities have been observed (3, 6).
A subset of homologous proteins in mammals, SNX13,
SNX14, SNX19, and SNX25, play important roles in cellular
signaling, trafficking, and development (3). Despite their
importance, however, no structural information is available on
this subfamily of SNX molecules. All but SNX19 possess a reg-
ulator of G-protein signaling (RGS) domain. RGS domains are
small -helical structures that act as GAPs for G subunits of
heterotrimeric G-proteins, and thus play critical roles in atten-
uating G-protein coupled receptor (GPCR) signaling (7, 8).
SNX13 (also called RGS-PX1) was identified as a specific GAP
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and regulator of the trimeric G-protein subunit Gs involved in
cAMP signaling from GPCRs such as the serotonin and -ad-
renergic receptors (9). Initial work isolated SNX13 following
searches for a potential GAP forGs G-protein isoforms, which
at the time had not been identified (9). SNX13 was shown to
both bind and promote GTPase activity of Gs, and attenuate
Gs-mediated signaling. Subsequent work found that SNX13
null mice were embryonically lethal, and yolk sac endoderm
cells of these embryos display highly disrupted endosomemor-
phology, suggesting that it plays a role in endosomal function
that is essential for normal development (10). SNX13 was also
shown to form a heteromeric complex on endosomeswith both
Gs and hepatocyte growth factor-regulated tyrosine kinase
substrate (Hrs), a component of the ESCRT pathway (11), and
influences the lysosomal targeting of the epidermal growth fac-
tor receptor, suggesting a role both in signal attenuation and
receptor trafficking (12). These findings regarding SNX13 may
be particularly important given the increasing recognition that
endosomes are critical sites of signal regulation for many types
of GPCRs and other signaling receptors (13–16).
Whether the RGS domains of SNX14 and SNX25 share this
GAP activity remains unknown. Recently Hao and colleagues
(17) demonstrated a role for SNX25 as a regulator of transform-
ing growth factor  (TGF-) signaling, binding to and promot-
ing the lysosomal trafficking and degradation of TGF- recep-
tors (TRs). Its increased expression in the temporal cortex has
also been correlated with temporal lobe epilepsy, although its
direct role in the disease has not been confirmed (18). The
SNX14 protein is expressed in motor neurons (19) and recent
studies suggest that the Snx14 gene is paternally imprinted in
neuronal cells, where it promotes synaptic transmission
through unknown mechanisms (20). SNX19 is the only mem-
ber of the family lacking an RGS domain (see below). It plays a
critical role in cartilage formation (chondrogenesis), and may
be a protective factor against the progression of cartilage deg-
radation in osteoarthritis, but like SNX14 its precise cellular
function is unknown (21).
In this studywe have examined the evolutionary and detailed
structural relationships between this subfamily of sorting nex-
ins, and characterized the specific phosphoinositidemembrane
binding activities of their PX domains. The proteins comprise a
novel modular protein family, with each member possessing a
predicted N-terminal transmembrane anchor, and four con-
served structural domains called the PXA, RGS, PX, and PXC
domains, except for SNX19, which appears to lack the RGS
module. These proteins also display a deep evolutionary heri-
tage, being present in all eukaryotes from humans to yeast.
However, our biochemical, structural, and cellular studies of
the PX domains of the mammalian proteins demonstrate an
unexpected diversity in phosphoinositide binding specificity,
with potential implications for their role in signal transduction
and membrane trafficking.
EXPERIMENTAL PROCEDURES
Molecular Biology—The cDNA encoding mouse SNX19-
(528–664) was cloned into the pMCSG10 vector for bacterial
expression with an N-terminal GST tag (22). The pMCSG10
vector encodes a tobacco etch virus (TEV) cleavage site. Syn-
thetic genes encoding the PX domains of human SNX13-(558–
677), SNX14-(561–686), and SNX25-(506–628) optimized for
Eschericia coli expressionwere purchased fromGeneart (USA),
and subsequently cloned into the pGEX-4T-2 vector for
expression as N-terminal GST fusion proteins with thrombin
cleavage sites. For cellular localization studies, genes encoding
full-length mouse SNX19 (residues 1–997) and the PX-PXC
domains (residues 528–997) were cloned into the pEGFP-N1
vector (Clontech) containing aC-terminalGFP tag. The SNX19
mutants were generated using the QuikChange II site-directed
mutagenesis protocol (Stratagene).
Recombinant Protein Expression and Purification—The plas-
mids encoding GST-PX domain fusions were transformed into
BL21(DE3)/pLysS E. coli cells, and expressed in LB broth at
37 °C untilA600 reached 0.8. The cultureswere inducedwith 0.5
mM isopropyl 1-thio--D-galactopyranoside and allowed to
grow at 20 °C overnight, and cells were harvested by centrifu-
gation (6000 g, 10min, 4 °C). The cell pellet was resuspended
in lysis buffer (20 mM Tris (pH 8.0), 200 mM NaCl, 50 g/ml of
benzamidine, 2 tablets of complete EDTA-free protease inhib-
itor, DNase I, 1 mM -mercaptoethanol). The purification was
performed using affinity chromatography with glutathione-
Sepharose, and when required the GST tags were cleaved by
TEV protease or thrombinwhile still bound to the column. The
proteins were eluted in 20mMTris (pH 8.0), 200mMNaCl, 10%
glycerol, and 1mMDTT,with the addition of 15mMglutathione
for non-cleavedGST fusions. ForNMRexperiments, uniformly
15N-labeled SNX19 and SNX14 PX domains were expressed in
minimal media containing 15NH4Cl and [13C]glucose as the
sole nitrogen and carbon sources.
SNX19 PX Domain Crystal Structure Determination—The
affinity purified and TEV-cleaved mouse SNX19 PX domain
(residues 528–664) was purified on a Superdex 200 gel filtra-
tion column in 10mMTris (pH 8.0), 200 mMNaCl, 5% glycerol,
and 1 mM DTT, and then 10 mM DTT was added prior to crys-
tallization. The SNX19 PX domain was then concentrated to
12–15 mg/ml for crystallization experiments. Eight commer-
cially available 96-well crystallization screens were set up using
aMosquito robot at 20 °C, and imaging performed using a Roc-
kimager system. Long needle crystals and plates grew rapidly in
many different conditions, totaling nearly 20% of the drops
(with somemicrocrystals appearing within seconds). The com-
mon factors for crystallization were the presence of polyethyl-
ene glycol (PEG) at concentrations between 15 and 30%, and
pH  7.0. Crystals optimized for diffraction were grown in
16–20% PEG 3350, 0.25–0.5 M NaCl, 5% glycerol, and 0.1 M
Tris (pH 8.5).
Crystals were cooled to 100 K under the cryostream after
immersing in mother liquor plus 20% glycerol. Data were col-
lected at theAustralian SynchrotronMX1Beamline, integrated
with iMOSFLM (23), and scaled with SCALA (24). The apo-
SNX19 PX domain structure was solved by molecular replace-
ment with PHASER (25) using as an input model the cytokine-
independent survival kinase PX domain (PDB code 1XTN)
after truncation to polyalanine. The resultingmodel was rebuilt
with COOT (26) and refined with PHENIX (27). Residues with
missing electron density suggesting structural disorder include
N-terminal residues 528–531, residues 569–577 within the
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loop between strands 2 and 3, and residues 616–626 within
the Pro-rich loop. The SO42-bound SNX19 PX domain struc-
ture was determined after soaking crystals in cryosolution con-
taining 100 mM Li2SO4 for 30 s before flash cooling to 100 K.
SNX14 PX Domain Crystal Structure Determination—The
affinity purified and thrombin-cleaved human SNX14 PX
domain (residues 561–686) was purified on a Superdex 200 gel
filtration column in 10 mM Tris (pH 8.0), 200 mM NaCl, 5%
glycerol, and 1mMDTT, and then 10mMDTTwas added prior
to crystallization. Crystallization screens were performed as for
the SNX19 PX domain. Large single crystals grew in a number
of conditions and the two conditions optimized for x-ray dif-
fraction experiments were 1.8 M ammonium citrate tribasic
(crystal form1) and 20%PEG4000, 0.1 M sodiumcitrate tribasic
(pH 4.5) (crystal form 2).
Crystals were cooled to 100 K under the cryostream after
immersing inmother liquor plus 20% glycerol. Data for crystals
in space group I41 (crystal form 1) was collected at the UQ
ROCX diffraction facility on a Rigaku FR-E Superbright gener-
ator with Osmic Vari-Max HF optics and Rigaku Saturn 944
CCD detector. Data for crystals grown in space group P43212
(crystal form 2) was collected at the Australian Synchrotron
MX1 Beamline. All data were integrated with iMOSFLM (23)
and scaled with SCALA (24). The SNX14 PX domain structures
were solved bymolecular replacementwithPHASER (25) using as
an inputmodel the SNX19PXdomain after truncation to polyala-
nine and removal of flexible loop regions.The resultingmodelwas
rebuilt with COOT (26) and refined with PHENIX (27).
Liposome Binding Assays—Small unilamellar vesicles were
prepared by the standard extrusion method. Lipids were dis-
solved in chloroform, and the solvent was removed under a N2
stream to yield a lipid film, which was left to dry under vacuum
overnight. The lipid film was hydrated with the desired buffer
uponagitation andeight freeze-thawcycles.The resulting suspen-
sions of multilamellar vesicles were extruded 21 times through
polycarbonate filters (1 m pore size) to obtain small unilamellar
vesicles. Different lipid compositions were used: PC/PE (70/30
molar percentage) composed of 70% of 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine and 30% of 1-palmitoyl-2-oleoyl phos-
phatidylethanolamine (Avanti Polar Lipids), and PC/PE contain-
ingPtdIns3P (EchelonBiosciences) (90:10molarpercentage)were
prepared to specifically test the effect of the PtdIns3P lipid. The
assay was conducted using 20 mM proteins and 1 mg/ml of small
unilamellar vesicles inassaybuffer (20mMHepes (pH7.5), 150mM
NaCl) in a total volume of 100l (mixture of 30l of protein and
70l of small unilamellar vesicles) and incubated at roomtemper-
ature for 20 min followed by centrifugation at 100,000 g (rotor
TLA100) for 15 min at 21 °C using a benchtop ultracentrifuge
(OptimaTLUltracentrifuge).The supernatantwas removed thor-
oughly andmixedwith 4 SDS sample buffer. Pelleted liposomes
were resuspended in100l of assaybuffer andmixedwith4SDS
sample buffer. The samples were boiled for 5min and centrifuged
at 9,000  g for 10 min. Supernatant (S) and pellet (P) fractions
were analyzed by SDS-PAGE and Coomassie Blue staining.
NMR Spectroscopy—Uniformly 15N-labeled proteins were
prepared in minimal media supplemented with 15NH4Cl. For
NMR chemical shift titration studies, soluble phosphoinositide
headgroup analogs with diC8 aliphatic chains (Echelon Biosci-
ences) were added to samples containing 50 M 15N-labeled
SNX19 or SNX14 PX domains in NMR buffer (20 mM Hepes
(pH 7.0), 100 mM NaCl, 10% D2O). Two-dimensional 1H-15N
HSQC spectra of either 15N-labeled SNX19 or SNX14 PX
domains were collected with increasing amounts of the soluble
phosphoinositide headgroup analogs. All spectra were col-
lected at 298 K on a Bruker 900-MHz spectrometer equipped
with a cryoprobe and Z-axis gradients. Spectra were processed
using NMRPipe (28) and analyzed with the programCCPNMR
(29).
Bioinformatics—To analyze the domain architecture of the
RGS-PX proteins, sequences were first subjected to secondary
structure predictions using JPRED (30). Proteins were then
subjected to multiple sequence alignments, which were manu-
ally adjusted to maximize alignment of predicted secondary
structure elements. For phylogenetic analysis, a multiple
sequence alignment was carried out using MUSCLE from
MEGA 5.1 under default settings. The alignments were then
used to construct a Maximum Likelihood Tree. The phylogeny
test selected was the Bootstrapmethod with 100 bootstrap rep-
lications. The sequences were obtained from NCBI and Uni-
Prot database.Accessionnumbers for sequences are supplied in
Table 1.
Immunofluorescence Microscopy—SNX19-GFP, SNX19 PX-
PXC-GFP (residues 528–997), SNX19 PX-PXC(R587Q)-GFP,
and SNX19 PX-PXC(R634K)-GFP were transfected into HeLa
cells using Lipofectamine 2000 (Invitrogen), according to
manufacturer’s instructions, and their localization was ana-
lyzed by immunofluorescence microscopy. Cells transfected
with each construct were immunolabeled against several sub-
cellular markers using the following antibodies: EEA1 (mouse
monoclonal anti-EEA1; BD Biosciences), LAMP1 (mouse mono-
clonal anti-LAMP1; BD Biosciences), and p230 (mousemonoclo-
nal anti-p230; BD Biosciences). Primary antibodies were immu-
nolabeled with donkey anti-mouse or goat anti-rabbit Alexa
Fluor 546 secondary antibodies (Invitrogen) and images were
collected using a Zeiss LSM510METAUpright Scanning Laser
confocal microscope. Colocalization quantification was per-
formed as previously described (31). Briefly, using ImageJ ver-
sion 64 the captured images were split into gray-scale formats,
threshold settings were applied to each individual channel and
Colocalization finder, the ImageJ plug-in, used to obtain a Pear-
son colocalization coefficient.
RESULTS
Defining the RGS-PX Protein Family—The four mammalian
proteins, SNX13, SNX14, SNX19, and SNX25, display a novel
and related architecture consisting of a central PX domain,
flanked by several conserved structures (Figs. 1 and 2).
Although we described these proteins in a recent review (3),
here we define their relationships in detail based on combined
sequence and structural considerations. The first domain
upstream of the PX domain is the RGS module, found in a
number of molecules that act as GAPs to attenuate GPCR-me-
diated G-protein signal transduction (7, 8). This domain is
found in SNX13, SNX14, and SNX25, but not in SNX19 where
the corresponding region, although similar in length, shows
little sequence homology andhas no predicted secondary struc-
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ture. For simplicity, and consistencywith previous reports (2, 9,
10, 12), we refer to this family herein as the RGS-PX proteins,
and include SNX19 despite lacking the RGS structure.
A second conserved but uncharacterized domain (200
amino acids in length) has previously been annotated based on
sequence homology and named the PX-associated (PXA)
domain (1–3). This domain is N-terminal to the RGS and PX
domain. Our secondary structure predictions and guided
sequence alignments indicate that the PXA domain is entirely
-helical; and in the case of SNX13 and SNX25 is followed by a
short (50 amino acids long) -helical region prior to the RGS
domain we refer to as the PXA segment. Secondary structure
comparisons further indicate the presence of a conserved
C-terminal domain found in all of these proteins (150 amino
acids long), which is also predicted to be entirely -helical in
structure. For consistent nomenclature we refer to the N- and
C-terminal domains as the PXA and PXC domains, respec-
tively, indicating they are PX-associated domains of unknown
structure and function. Note, however, that the PXA and PXC
domains are not related to each other, either by sequence
homology or secondary structure similarity. Finally, all pos-
sess two N-terminal predicted trans-membrane helices.
Analysis using the SignalP3.0 server (32) suggests the first
N-terminal hydrophobic segment is a transmembrane
anchor that is unlikely to be removed by signal cleavage.
These molecules are therefore predicted to be two-pass
transmembrane proteins with a short cytoplasmic N termi-
nus, a very short extracellular or lumenal loop, and a long
and highly modular cytoplasmic C-terminal structure con-
sisting of three to four globular domains interspersed by
variable linker regions.
Although human SNX25 is annotated in several protein
databases as lacking the N-terminal transmembrane helices,
and studies of SNX25have used constructs lacking such regions
(17), our comparisons of the rat, mouse, and human genomes
clearly identify conserved N-terminal coding sequences that
are transcribed and contain the two predicted transmembrane
segments. Thus putative transmembrane anchors are common
to all members of the family (Figs. 1 and 2A).
In addition to the mammalian RGS-PX proteins a related
protein, Mdm1p, is reported to play a role in mitochondrial
inheritance in Saccharomyces cerevisiae (33–36). The original
articles outlining Mdm1p cloning and function describe a 443-
residue protein that begins with the sequence “MEKV.” Based
on this reported sequence Mdm1p has the C-terminal PX
and PXC domains, but not the N-terminal PXA or RGS
domains (12). However, the current annotated S. cerevisiae
genome sequence encodes a protein of 1127 amino acids,
where the original published sequence represents a C-termi-
nal subfragment (residues 685–1127) (Fig. 2A). Examination
of secondary structure predictions of this longer sequence
indicates Mdm1p has essentially identical domain arrange-
ments to mammalian SNX13 and SNX25; i.e. PXA, PXA,
RGS, PX, and PXC domains, and two predicted N-terminal
transmembrane helices. The Drosophila melanogaster snazarus
protein also possesses all putative domains. Therefore
Mdm1p and snazarus are bona fide homologs of the mam-
malian RGS-PX proteins, and this protein family clearly has
a deep eukaryotic evolutionary heritage. A phylogenetic tree
of the RGS-PX proteins from vertebrates, invertebrates, and
unicellular species confirms their conservation in all eukary-
otic organisms (Fig. 2B).
Analysis of RGS-PX transcripts in mouse using the BioGPS
server (37) suggests a broad pattern of expression for SNX13,
SNX14, and SNX19, whereas SNX25 is highly elevated in
lung samples. This is consistent with published Northern blots
TABLE 1
Accession numbers for RGS-PX protein sequences
The sequences were obtained from NCBI and UniProt databases.
SNX13 SNX14 SNX19 SNX25 Snazarus Mdm1p
Human Q9Y5W8 Q9Y5W7 Q92543 This study
Homo sapiens
Chimpanzee JAA36856 JAA40159 JAA43654 JAA34955
Pan troglodytes
Macaque AFE64496 AFH28856 AFH32382 AFE66285
Macaca mulatta
Mouse NP_001014973 NP_766514 NP_083150 AAT98626
Mus musculus
Rat NP_00156765 NP_001101644 NP_001101601 EDL78878
Rattus norvegicus
Chicken XP_00123468 NP_001034378 XP_003642646 XP_420506
Gallus gallus
Western clawed frog XP_002933347 NP_001085023 XP_002938154 ENSXETT00000064280
Xenopus tropicalis
Zebrafish XP_003200556 NP_001038258 XP_697433 NP_001156765
Danio rerio
Worm XP_002125747 XP_002122266 XP_002120443
Ciona intestinalis
Roundworm NP_503026 NP_496844
Caenorhabditis elegans
Fruitfly Q9W3N0
D. melanogaster
Yeast C8ZE98
S. cerevisiae
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of SNX25, which show the highest level of expression in lung,
with lower but significant expression in brain and spleen (17).
Previous Northern blot and in situ hybridization analyses and
Western blots of mouse tissues suggest higher levels of SNX14
expression in the nervous system (19, 20).
The PXDomains of the RGS-PXProteins ShowDifferent Phos-
phoinositide Binding Preferences—The PX domains of yeast PX
proteins have been found to interact almost exclusivelywith the
endosomal lipid PtdIns3P, and this includes the RGS-PX family
member Mdm1p (38). However, our previous survey of the lit-
erature on mammalian PX domains highlighted a broader
phosphoinositide binding capability that may drive recruit-
ment to a greater diversity of cellular organelles andmembrane
domains (3). For the canonical interaction with PtdIns3P,
structures of p40phox (39), SNX9 (40, 41), and the yeast Snx3p/
Grd19p molecule (42) in complex with the lipid headgroup
reveal four side chains required for binding. These are an Arg
and Tyr pair found in the loop between 3 and 1, a Lys within
an extended Pro-rich loop, and an Arg within helix 2, labeled
as residues 1, 2, 3, and 4, respectively in Fig. 3, A and B. These
side chains provide critical contacts with the 3-phosphate, ino-
sitol ring, 1-phosphate, and 4- and 5-hydroxyls of the PtdIns3P
molecule, respectively. Within the RGS-PX subfamily SNX13
and SNX19 possess these conserved residues required for
PtdIns3P binding, and SNX14 has a conservative substitution
of Arg to Lys at the hydroxyl-coordinating site 4. SNX25 how-
ever, has combined substitutions of the key hydroxyl-binding
Arg side chain 4 to Ser, and the Tyr at site 2 necessary for
inositol ring stacking to Leu, which would alter the pocket sig-
nificantly and would be predicted to perturb the typical
PtdIns3P association (Fig. 3, A and B).
To test binding of the PX domains from the RGS-PX family
to phosphoinositides, we employed a liposome pelleting assay
incorporating artificial liposomes of different compositions
(Fig. 3C). Using PC/PEmembranes as controls, we observe spe-
cific binding to liposomes containing the endosomal PtdIns3P
lipid. Using this assay both SNX13 and SNX19 showed robust
interactions with membranes supplemented with PtdIns3P.
This is in line with the conservation of PtdIns3P-coordinating
side chains for these proteins (Fig. 3, A and B). Interestingly,
despite the relatively minor and conservative change in the
SNX14 binding this protein did not bind to membranes. The
SNX25 PX domain also does not display significant PtdIns3P,
consistent with the idea that its altered binding pocket is unable
to coordinate this phosphoinositide in the usual manner.
Next, using NMR spectroscopy with soluble phosphoinosit-
ide headgroup analogs, we confirmed the results of the lipo-
some pelleting assays for the SNX14 and SNX19 PX domains,
which display differential recognition of endosomal PtdIns3P
(Fig. 4). Although we have not assigned the backbone spectra
for these domains, 1H-15N HSQC spectra for 15N-labeled sam-
ples of both proteins arewell dispersed and suitable for titration
studies. Supporting the liposome pelleting assays of Fig. 3C, we
find that SNX14 does not appear to bind specifically to
PtdIns3P, or any other phosphoinositide species tested,
whereas SNX19 shows a specific interaction with PtdIns3P,
with a number of peaks in the 1H-15NHSQC spectrum showing
FIGURE 1. Secondary structure-based sequence alignment of human RGS-PX proteins SNX13, SNX14, SNX19, and SNX25. Secondary structure predic-
tions calculated with JPRED (30) are indicated for SNX13 (above) and SNX19 (below). For the region encompassing the SNX19 PX domain, secondary structure
information is derived from the crystal structure. The alignment wasmadewith ESPript 2.2 (49). In addition to the four conserved domains, SNX13 and SNX25
possess an additional regionwith the predicted helical structure designated here as PXA that lies between the PXA andRGSdomains. SNX19 lacks a predicted
RGS domain.
FIGURE 2. The RGS-PX proteins are modular multidomain proteins con-
served in all eukaryotes. A, architectures of the human SNX13, SNX14,
SNX19, SNX25, and yeast Mdm1p proteins are shown to scale. Crosses indi-
cate where particular domains are not present. The dashed box indicates the
region of Mdm1p that was previously characterized (33–36). A full sequence
alignment of the four human proteins is presented in the legend to Fig. 1. B,
the maximum likelihood phylogenetic tree for RGS-PX proteins including 39
sequences from vertebrates, invertebrates, and unicellular species (Table 1.
The tree was constructed in MEGA 5.1 with the Bootstrap method as Test of
Phylogeny (100 bootstrap replications) and was rooted using yeast Mdm1p
as the outgroup.
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clear line broadening on the addition of the headgroup consis-
tent with direct association.
Crystal Structures of the SNX14 and SNX19 PX Domains—
To better understand themolecular basis for why SNX19 binds
to PtdIns3P but SNX14 does not we determined their x-ray
crystallographic structures (Fig. 5, Table 2). The mouse SNX19
PX domain was crystallized in space group P21 with two copies
in the asymmetric unit. The SNX19 PX domain displays the
canonical PXdomain fold composed of three-strands (1-3)
followed by three -helices (1-3), with a long and flexible
loop between 1 and 2 that contains a conserved Pro residue
that likely contributes to this flexibility. The mouse SNX19 PX
domain is 97% identical to human SNX19 and no significant
structural differences are expected between the two species.
However, the sequence similarity of the PX domains across the
four different members of the mammalian RGS-PX family is
relatively low, with pairwise identities of only between 17 and
29% (Fig. 3A).
ThehumanSNX14PXdomain crystallized in twodistinct crys-
tal forms, and structures were determined in space groups I41
(crystal form 1) and P43212 (crystal form 2) at 2.5- and 3.0-Å res-
olution, respectively. As thisworkwas underway, a third structure
of the human SNX14 PX domain was deposited in the Protein
Data Bank (PDB) by the Yue lab (51) of Oxford University and
colleagues of the Structural Genomics Consortium (PDB code
4BGJ). The deposited structure is analogous to crystal form 1
reportedhere,with thesamespacegroup(I41)andunit cellparam-
eters and an overall rootmean square deviation of 0.98Åover 102
C atoms.Crystal form2 (P43212) has four copies of SNX14 in the
asymmetric unit; and six SNX14 molecules compared across the
three crystal structures are very similar with an root mean square
deviations varying from 0.8 to 1.1 Å (see Fig. 7F).
FIGURE 3. Phosphoinositide binding by the PX domains of themammalian RGS-PX proteins. A, sequence alignment of the PX domains from human and
mouse RGS-PX proteins. The secondary structures of human SNX14 andmouse SNX19 as determined from their crystal structures (see Fig. 5) are indicated at
the top and bottom, respectively. The four key consensus PtdIns3P-binding residues are indicated by numbered circles from 1–4 as in B. B, summary table
comparing the putative key PtdIns3P-binding residues of the RGS-PX proteins to the canonical PtdIns3P binding side chains identified in previous PX domain
complex structures (3). Each of the four consensus residues is numbered from 1 to 4. C, liposome pelleting assay for PX domains of SNX13, SNX14, SNX19, and
SNX25. GST fusion proteins were incubated with the indicated artificial liposomes, or buffer as a control. Samples were subjected to ultracentrifugation
followed by SDS-PAGE and Coomassie staining of the unbound supernatant S and bound pellet P fractions. Both SNX13 and SNX14 bind liposomes supple-
mented with PtdIns3P, whereas SNX14 and SNX25 do not.
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Although the SNX14 and SNX19 PX domains can be struc-
turally alignedwith an rootmean square deviation of 1.9 Å over
93 C atoms, there are major differences in some structural
elements (Figs. 5 and 6). Notably, SNX19 has an extended
-sheet structure compared with SNX14 (and other PX
domains) as well as an additional short -helix we call 1,
whereas the SNX14 2 helix possesses a significant kink com-
pared with SNX19 and other PX proteins. Both PX domains
possess electrostatically polar surfaces, notably retaining a sig-
nificant basic patch at the site expected to bind to negatively
charged phosphoinositide headgroups (Fig. 5). The top three
structural matches to both SNX19 and SNX14 using the DALI
FIGURE 4. Phosphoinositide binding of SNX14 and SNX19 PX domains assessed by NMR. 1H-15N HSQC spectra of 15N-labeled SNX14 and SNX19 PX
domains are shown in the presence and absence of soluble phosphoinositides. Spectra were recorded at 25 °C using 50 M PX domains. In line with the
liposome pelleting assays (Fig. 3C) SNX14 shows no significant binding to any of the phosphoinositides tested, whereas SNX19 shows clear interaction with
PtdIns3P as shown by the number of specific chemical shift perturbations observed.
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web server (43) were the PX domains of serum/glucocorticoid-
regulated kinase 3, SNX7, and phosphatidylinositol 4-phos-
phate 3-kinase C2 (PI3K-C2), although a number of PX pro-
teins gave similar high alignment scores, highlighting the
conserved structural profile of the family. Fig. 6 shows a com-
parison of SNX19 and SNX14 to several of these. Of the known
PX domain structures the protein with the most dramatically
different architecture is SNX5. SNX5 is a member of the BAR
(Bin/amphiphysin/Rvs) domain-containing subfamily (44), and
its PX domain (and that of close homologs SNX6 and SNX32)
has a large and unique helical hairpin insertion between helices
1 and 2. The functional significance of this insertion still
remains unclear, but it has been suggested to confer altered
membrane binding and remodeling properties to this subset of
SNX-BAR proteins (3). Recently, the structure of the SNX11
PX domain was reported to possess a novel extended -helical
FIGURE 5. Crystal structures of themouse SNX19 and human SNX14 PX domains. Left panels show back and front views of the overall structures of the PX
domains and right panels show a surface representation of the (A) mouse SNX19 and (B) human SNX14 proteins. The ribbon structure of SNX19 is colored dark
blue to gray from the N to C terminus. The ribbon structure of SNX14 is colored dark green to light green from the N to C terminus. Surfaces are colored by
electrostatic potential from 0.5 to 0.5 V. Both SNX19 and SNX14 possess a pocket of high positive charge in the approximate location of the putative
phosphoinositide binding site.
TABLE 2
Summary of crystallographic structure determination statistics
Highest resolution shell is shown in parentheses.
SNX19 PX
domain apo
SNX19 PX domain
SO42 bound
SNX14 PX domain
(crystal form 1)
SNX14 PX domain
(crystal form 2)
Data collection
Wavelength (Å) 0.9537 0.9537 1.54187 0.95370
Space group P21 P21 I41 P43212
Cell dimensions
a, b, c (Å) 63.8, 32.9, 81.9 64.2, 33.0, 82.5 86.9, 86.9, 74.4 121.7, 121.7, 82.4
, ,  (°) 90, 107.5, 90 90, 107.2, 90 90, 90, 90 90, 90, 90
Resolution (Å) 31.7-1.90 (2.00-1.90) 78.8-2.40 (2.53-2.40) 22.10-2.55 (2.69-2.55) 68.2-3.00 (3.16 (3.00)
Rmerge 0.104 (0.561) 0.097 (0.576) 0.082 (0.682) 0.140 (1.049)
I/(I) 15.1 (3.3) 13.4 (3.4) 15.4 (1.9) 20.9 (4.7)
Completeness (%) 99.9 (100.0) 99.4 (99.4) 99.8 (99.3) 100.0 (100.0)
Number unique reflections 26,154 (3,782) 13,235 (1,909) 9,073 (1,318) 12,933 (1,839)
Redundancy 7.3 (7.3) 7.0 (7.1) 6.5 (3.8) 27.8 (28.8)
Wilson B-factor 18.3 47.7 72.3 89.5
Refinement
Resolution (Å) 30.44–1.90 (1.98–1.90) 61.28–2.40 (2.64–2.40) 22.1–2.55 (2.92 -2.55) 48.9–3.00 (3.30–3.00)
No. reflections/No. Rfree 25,639/1,300 12,772/629 9,067/432 12,883/629
Rwork/Rfree 0.213/0.247 0.221/0.263 0.183/0.209 0.234/0.285
No. atoms
Protein 1,896 1,892 915 3475
Solvent 309 84 23 19
No protein chains per asymmetric unit 2 2 1 4
Average B-factor (Å2) 25.2 48.3 53.6 92.7
Root mean square deviations
Bond lengths (Å) 0.007 0.008 0.010 0.011
Bond angles (°) 0.983 1.016 1.260 1.452
PDB code 4P2I 4P2J 4PQO 4PQP
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structure (also present in SNX10), which is required for its reg-
ulation of endosomal vacuolization (45).
Structural Basis for the Different Phosphoinositide Prefer-
ences of the SNX19 and SNX14 PXDomains—As shown in Figs.
3C and 4, SNX19 specifically associates with PtdIns3P, whereas
SNX14 lacks this binding activity. We attempted to soak
SNX19 crystals with soluble PtdIns3P (and other phosphoi-
nositide analogs) but did not observe any lipids bound within
the putative binding pocket, most likely due to occlusion by
crystal packing. Notably the Pro-rich loop is restricted at its
distal C terminus by a crystal contact and therefore may be
unable tomake theminor conformational alterations necessary
for PtdIns3P binding.Nonetheless, the four key side chains nor-
mally required tomediate PtdIns3P binding are all present, and
approximately poised to support PtdIns3P interaction. Previ-
ous reports have shown that SO42 ions can be coordinated by
the site 1 Arg side chain where the 3-phosphate group is nor-
mally bound (46, 47), so we next soaked crystals with Li2SO4
and observed a clear difference density for a SO42 ion bound to
the analogous SNX19 side chain Arg587 (Arg582 in human
SNX19) (Fig. 7, A and B). Comparisons with PtdIns3P-bound
SNX9 (40, 41) and p40phox (39) confirm specific coordination
of the SO42 ion in exactly the same location as the PtdIns3P
3-phosphate groupwould be expected to bind (Fig. 7A). Overall
this is strong evidence of a viable PtdIns3P binding site within
the SNX19 PX domain, and given the similar ability of SNX13
to bind PtdIns3P membranes (Fig. 3C), and the conservation
of the required binding side chains, it is likely that SNX13
shares a similar PtdIns3P binding pocket. To confirm the
importance of the binding site, we generated a mutant SNX19
PX domain (R587Q) and tested its associationwithmembranes
in liposome pelleting assays (Fig. 7C). As expected this point
mutant no longer binds PtdIns3P-containing membranes
above background levels.
In contrast to SNX19, we find that SNX14 does not bind
PtdIns3P-containingmembranes (Fig. 3C). Closer examination
of the putative phosphoinositide-binding site reveals key alter-
ations that explain this lack of phosphoinositide association
(Fig. 7D). First, whereas the side chains at sites 1, 2, and 3 are
conserved and approximately oriented for binding the head-
group, the fourth side chain at site 4 is altered from Arg to Lys
(Lys656), and is pointed away from the binding site, stabilized by
interaction with the side chain of Glu659 (density for the Lys656
side chain is shown in Fig. 7E, and the side chain is similarly
oriented in all molecules of the asymmetric units in the two
crystal forms). Overall the Pro-rich loop is well ordered, unusu-
ally formost PX domains, and is in fact stabilized by a hydrogen
bond between the backbone carbonyl of Pro640 within the loop
and the side chain of Tyr621 within helix 1. A network of core
interactions between Leu639, Tyr621, Tyr617, and Phe652 overall
contribute to the formation of a relatively closed pocket, and in
addition Lys648 is prominently positioned in such a way as to
sterically interferewith potential PtdIns3P headgroups. Surface
representations of the domain demonstrate that the normal
mode of PtdIns3P coordination would be completely excluded
(Fig. 7D). In the three combined crystal structures of the SNX14
PX domain there are a total of six identical protein chains
within the asymmetric units. All chains adopt a similar closed
conformation of the putative PtdIns3P-binding pocket with the
exception of chain A in our crystal form 2. In this chain, the
pocket adopts a slightly different conformationwhere the bind-
ing pocket is even more severely occluded (green chain in Fig.
7F). To summarize, replacement of the site 4 Arg side chain to
Lys, and key alterations in the binding pocket geometry appear
to exclude the canonical phosphoinositide association with
SNX14.
In support of the key role of Lys656 in the abrogation of
PtdIns3P binding we engineered a SNX14 mimicking substitu-
tion in the SNX19 PX domain, altering the equivalent site 4
Arg634 to Lys (R634K). This mutant, similarly to R587Q,
reduces PtdIns3P liposome interactions to background levels
(Fig. 6C). Although it is unlikely that the SNX19 R634Kmutant
completely mimics the closed binding pocket architecture of
SNX14, as this is also promoted by other key side chains, this
result shows that simply altering the site 4 Arg to Lys is suffi-
cient to perturb the normal PtdIns3P interactions.
Localization of SNX19 to a Subpopulation of Endosomes
Requires PtdIns3P Interaction—Previous studies of the cellular
localization of exogenously expressed and truncated forms of
SNX13 (9, 12) and SNX25 (17) have shown members of this
family to be on endosomal organelles. In the case of SNX13 a
construct containing the C-terminal RGS, PX, and PXC
FIGURE 6. Comparison of SNX14 and SNX19 PX domain structures with
other PXdomainproteins. The structures of SNX19 and SNX14 are shown in
comparison with their two closest structural matches SNX7 and serum/glu-
cocorticoid-regulated kinase 3 (50), as well as the structurally divergent PX
domain from SNX5, which has a highly extended -helical hairpin insertion
following the Pro-rich loop (44), and the SNX11 PX domain shown to possess
extended -helical structure at the C terminus important for its function (45).
-Strands are indicated in gold, and -helices in blue. The SNX19 PX domain
has a significantly elongated -sheet substructure compared with other PX
domainproteins, includingSNX14.Unique to SNX19 is thepresenceof a short
helical insert we designate as 1 between helices 1 and 2, and preceding
the Pro-containing loop.
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domains is localized to endosomes (9, 12). In the case of mouse
SNX25, the PX domain is sufficient for endosomal localization,
although the N-terminal PXA domain can also associate with
endosomal membranes in isolation (17). To date no studies
have reported the localization of a full-length RGS-PX pro-
tein, due to poor expression, lack of antibodies to the endog-
enous proteins, or incompletely cloned sequences. We thus
attempted to assess the cellular localization of the full-length
SNX19 protein with a C-terminal GFP tag (to avoid interfer-
ence with putative N-terminal transmembrane domains), how-
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ever, this construct was not expressed well and showed diffuse
labeling (Fig. 8A). Following previous examples of truncated
SNX13 (9) and SNX25 (17) we engineered a construct of
SNX19with only the C-terminal PX and PXC domains (SNX19
PX-PXC; residues 528–997). This construct strongly labeled
cytoplasmic puncta (Fig. 8A), and showed partial overlap with
the early endosomal marker EEA1 (Pearson colocalization
coefficient 0.1559  0.0207 S.D.), but no correlation with the
late endosomal marker LAMP1 (Pearson colocalization coeffi-
cient 0.0167  0.0018 S.D.) or trans-Golgi network marker
p230 (Pearson colocalization coefficient 0.0261 0.0176 S.D.)
(Fig. 8B), indicating its recruitment to a subset of endosomal
organelles similarly to other RGS-PX family proteins. Confirm-
ing the importance of PtdIns3P binding for membrane associ-
ation of this SNX19-C-terminal fragment, we find that the
SNX19 PX-PXC (R587A) mutant is no longer localized to
punctatemembrane structures and shows a diffuse cytoplasmic
labeling (Fig. 8A). Similarly, theSNX19PX-PXC(R634K)mutant,
whichmimics the substitution of the site4Arg to Lys as in SNX14
andblocksPtdIns3P, association is alsono longermembraneasso-
ciated (Fig. 8A). Altogether, the data shows PtdIns3P interaction
by the SNX19 PX domain mediates association with endosomal
membranes, andsuggests thealteredbindingpocketofSNX14will
not be able to support endosomal recruitment.
DISCUSSION
Members of the RGS-PX protein family are important for
GPCR-mediated signaling via Gs trimeric G-protein subunits
(9), signaling by TGF (17), endosomal trafficking (12), and
normal cellular development in different eukaryotic organisms
(10, 35, 48). Our analyses indicate that the proteins are con-
served across the entire eukaryotic lineage, with unicellular and
invertebrate genomes containing a single isoform, and appar-
ent gene expansion occurring in vertebrates with mice and
humans possessing four paralogs. Across all species the
RGS-PX proteins possess a similar modular architecture with
domains of both known and unknown structure and function.
Although the RGS-PX family members possess highly con-
served putative transmembrane domains, the importance of
these domains for cellular localization or protein function is
still unknown. Expression of a tagged full-length SNX19 in our
hands leads to diffuse cellular localization, which is distinct
from the punctate endosomal membrane recruitment of vari-
ous ectopically expressed RGS-PX truncation variants incorpo-
rating the PX and PXC domains of SNX13 (9), SNX25 (17), and
SNX19 itself (this study). The development of antibodies to the
endogenous proteins will likely be necessary to properly char-
acterize membrane localization of the full-length proteins and
confirm whether they are truly integral membrane proteins.
The RGS domain of SNX13 has been shown to possess GAP
activity andmediate subsequent signal attenuation of Gs-cou-
pled GPCRs (9), but it remains to be determined whether other
family members possessing this domain (SNX14 and SNX25)
have similar or divergent activities. The PXA and PXCdomains
of these proteins remain the most poorly characterized
domains of all. Whereas they are predicted to possess -helical
structures, they are not identified as belonging to any known
protein-fold class, and their functions have not been directly
determined to date. The SNX25 PXA domain possesses an
intrinsic ability to localize to EEA1-positive early endosomes,
and can cooperate with the PX domain to interact with TRs
and promote their lysosomal degradation, suggesting a mem-
brane targeting and/or protein-interaction activity (17). But
further studies of these domains will be required to define their
functional roles.
In this work we have focused on the membrane targeting
activities of the PX domain of the RGS-PX family. The four
mammalian RGS-PX paralogs show significant divergence in
the sequences of their PX domains, with distinct differences in
the side chains that are normally required for binding the early
endosomal phosphoinositide PtdIns3P. Our data shows a clear
pattern of phosphoinositide binding preference related to the
differences in these residues. Notably, SNX25 lacks two of the
four side chains required for PtdIns3P association, and does not
show interaction with PtdIns3P-containing liposomes in vitro.
Themechanism by which the SNX25 PX domain is localized to
endosomal membranes (17) therefore remains unclear. Both
SNX13 and SNX19 retain the canonical residues at the 1, 2, 3,
and 4 sites for coordination of PtdIns3P, both share the ability
to recognizemembranes enriched in this lipid, and this binding
pocket is required for membrane association in vivo. However,
our studies show that a relatively minor alteration in SNX14 at
site 4, with the typical hydroxyl-coordinating Arg side chain
modified to Lys, combined with changes in several key residues
surrounding the pocket, leads to a profound alteration of the
binding pocket architecture. The pocket is thus occluded and
unable to accommodate PtdIns3P in the usual way, explaining
FIGURE 7. Structures of the SNX19 and SNX14PXdomains explain their different PtdIns3Pbinding affinities.A, structure of SNX19 PX domain bound to
SO4
2, and comparison with the structure of the PtdIns3P bound PX domain from p40phox (39). The four key PtdIns3P-coordinating side chains are shown for
both proteins. The four side chains of SNX19 are poised in the correct orientations to bind a potential PtdIns3P lipid, and the SO4
2 ion is bound in the same
location as the 3-phosphate groupof the PtdIns3P headgroup in p40phox. B, electron density of the SNX19 PXdomainwith bound SO4
2 ion. The image shows
a close up of the putative PtdIns3P-binding pocket. Refined 2Fo Fc density contoured at 1.0 is shown inwall-eye stereo view. C, liposome pelleting assay of
SNX19 PX domain and structure-based mutations of the phosphoinositide binding pocket. Mutation of the 3-phosphate binding Arg587 at site 1 to Gln
abrogates interaction with PtdIns3P-containing membranes. Mutation of the Arg634 side chain at site 4 to Lys (as in the SNX14 PX domain) also inhibits
membrane association.D, in theupper panel the potential phosphoinositide bindingpocket of the SNX14PXdomain is shown inwall-eye stereo view,with key
side chains indicated. Also included is the PtdIns3P headgroup as it would be expected to bind based on an overlay of SNX14 with the p40phox-PtdIns3P
complex. The lower panel shows a similar stereo viewof the SNX14 structure in surface representation colored for electrostatic potential (from0.5 to0.5 V).
As discussed in the text, despite the presence of a negatively charged surface, the required pocket is completely occluded due to a number of key alterations
in the surrounding residues. E, electrondensity of the SNX14PXdomain (chainA in spacegroup I41). The image showsa closeupof theoccluded region around
the putative PtdIns3P binding pocket. Refined 2Fo Fc density contoured at 1.0  is shown in wall-eye stereo view. F, an overlay of the four molecules of the
SNX14 PX domain in the asymmetric unit of crystal form 2 is shown, along with the structure of SNX14 in space group I41 (crystal form 1) (this study) and PDB
coordinates 4BGJ available from the PDB. Chain A in crystal form 2 adopts an even more closed conformation of the putative PtdIns3P binding pocket than
other chains as represented in Fig. 6C (green worms).
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the lack of PtdIns3P recognition. The localization of SNX14 in
cells remains to be determined, but our prediction is that it will
not be stably associated with PtdIns3P-enriched endosomal
membranes in the same way as SNX13 and SNX19. This pre-
diction is partly supported by the observation that SNX19 with
a substitution in the Arg at position 4 to Lys (thus partly mim-
FIGURE 8.Endosomal localizationof theSNX19protein requires PtdIns3P interaction.A, subcellular localization of full-length SNX19-GFP, SNX19PX-PXC-
GFP, SNX19 PX-PXC-GFP R643K, and SNX19 PX-PXC-GFP R643K proteins in HeLa cells. Full-length SNX19-GFP shows a diffuse cellular localization, whereas the
C-terminal SNX19 PX-PXC-GFP fragment is foundonpunctatemembranes. SNX19 R587QPX-PXC-GFP and SNX19R643K PX-PXC-GFP are both redistributed to
the cytoplasm indicating an essential role for these side chains in membrane targeting. B, the punctate membranes positive for SNX19 PX-PXC-GFP overlap
with EEA1 (early endosome) but not LAMP1 (late endosomes/lysosomes) or p230 (Golgi) subcellular localizationmarkers. All images represent a 1 absorbance
unit single slice captured using a Zeiss LSM 510 META Upright Scanning Laser confocal microscope at63 magnification. Scale bar, 10 m.
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icking SNX14) is no longer recruited normally to membranes
either in vitro or in cells.
In conclusion, our data shows that small alterations in the
core residues of the phosphoinositide binding pocket can sig-
nificantly alter themembrane specificity of the PX domain.We
propose that the highly conserved RGS-PX proteins will coor-
dinate regulatory protein-protein interactions via PXA and
PXC domains with GAP activity via the RGS domain to assem-
ble complexes necessary for modulating cell signaling, whereas
the coupling of differential phosphoinositide preferences
within the PX domain will act to promote the formation of
these complexes in different domains of the endocytic and
secretory system to guide distinct signaling outcomes.
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